海南医学
海南醫學
해남의학
HAINAN MEDICAL JOURNAL
2014年
14期
2135-2137
,共3页
内镜下套扎术%食管胃底静脉曲张出血%疗效
內鏡下套扎術%食管胃底靜脈麯張齣血%療效
내경하투찰술%식관위저정맥곡장출혈%료효
Esophageal variceal ligation%Bleeding esophageal varices%Effectiveness
目的:观察并评价内镜下套扎术(Esophageal variceal ligation,EVL)联合药物治疗食管胃底静脉曲张出血(BEGV)的有效性及安全性。方法选取2011年5月至2012年9月笔者所在医院接诊的112例BEGV患者,按照治疗方式的不同将患者分成观察组和对照组各56例。观察组患者接受内镜下EVL术联合药物治疗,而对照组患者仅接受药物治疗。所有患者均随访一年,统计患者的治疗效果及不良反应发生的情况。结果观察组患者食管胃底静脉曲张消失、止血成功和BEGV复发例数分别为53例、55例和3例,对照组分别为42例、46例和11例;观察组不良反应发生率为5.4%,对照组为28.6%;上述各项指标比较差异均具有统计学意义(P<0.05)。结论 EVL联合药物治疗BEGV疗效显著,且安全可靠,值得临床上进一步推广应用。
目的:觀察併評價內鏡下套扎術(Esophageal variceal ligation,EVL)聯閤藥物治療食管胃底靜脈麯張齣血(BEGV)的有效性及安全性。方法選取2011年5月至2012年9月筆者所在醫院接診的112例BEGV患者,按照治療方式的不同將患者分成觀察組和對照組各56例。觀察組患者接受內鏡下EVL術聯閤藥物治療,而對照組患者僅接受藥物治療。所有患者均隨訪一年,統計患者的治療效果及不良反應髮生的情況。結果觀察組患者食管胃底靜脈麯張消失、止血成功和BEGV複髮例數分彆為53例、55例和3例,對照組分彆為42例、46例和11例;觀察組不良反應髮生率為5.4%,對照組為28.6%;上述各項指標比較差異均具有統計學意義(P<0.05)。結論 EVL聯閤藥物治療BEGV療效顯著,且安全可靠,值得臨床上進一步推廣應用。
목적:관찰병평개내경하투찰술(Esophageal variceal ligation,EVL)연합약물치료식관위저정맥곡장출혈(BEGV)적유효성급안전성。방법선취2011년5월지2012년9월필자소재의원접진적112례BEGV환자,안조치료방식적불동장환자분성관찰조화대조조각56례。관찰조환자접수내경하EVL술연합약물치료,이대조조환자부접수약물치료。소유환자균수방일년,통계환자적치료효과급불량반응발생적정황。결과관찰조환자식관위저정맥곡장소실、지혈성공화BEGV복발례수분별위53례、55례화3례,대조조분별위42례、46례화11례;관찰조불량반응발생솔위5.4%,대조조위28.6%;상술각항지표비교차이균구유통계학의의(P<0.05)。결론 EVL연합약물치료BEGV료효현저,차안전가고,치득림상상진일보추엄응용。
Objective To observe and evaluate the effectiveness and safety of esophageal variceal ligation (EVL) combined drug for esophageal and gastric varicose bleeding (EGVB). Methods A total of112 cases of EGVB in our hospital from May 2011 to September 2012 were selected and divided into observation group and control group according to the different treatment methods. The observation group received EVL combined with drug therapy, while the control group received drug treatment only. All the patients were followed up for 1 year, and then the therapeutic effect and adverse reactions were recorded. Results The number of patients with disappeared EGVB, successful he-mostasis and EGVB recurrence in the observation group were 53, 55 and 3 respectively, which in the control group were 42, 46 and 11 respectively. Incidence of adverse reactions in the observation group and the control group were 5.4%and 28.6%respectively, with statistically significant different (P<0.05). Conclusion EVL combined with drug therapy has a significant effect on treatment for BEGV with good safety and reliability. Therefore, it's worthy of fur-ther clinical application.